(Q68132897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Robert C. Stein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

M Dowsett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A Mehta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

I E Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

T J Powles

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

R C Coombes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

415-420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Serum kinetics of the anti-cancer agent 4-hydroxyandrostenedione in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

Inhibition of estrogen biosynthesis and regression of mammary tumors by aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980065-6

7 January 2021

10.1016/S0959-8049(05)80065-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1591054%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference